Pathways' Pick of the Week: EU Medtech Seeks Reforms

article image
ARTICLE SUMMARY:

MedTech Europe calls for comprehensive MDR and IVDR reforms. Excerpted from Pathways Picks November 8: EU Reform, Medicare Rules, Cyber Picks, and More.

MedTech Europe doubled down and expanded on demands for “comprehensive reform” of the EU Medical Device and IVD Regulations in a position paper published November 7. “While considerable work has been done by all stakeholders to address the short-term implementation challenges, there are structural issues in the regulatory system which make it slow, unpredictable, costly and complex, and lacking in agile pathways for innovation,” the trade group writes. The paper reaffirms some reform requests outlined in an open letter sent in September to the EU Health Commissioner by 34 organizations including MTE and adds more changes for consideration. Key reforms floated by the industry trade association include:

  • Allowing notified bodies to be more flexible in weighing benefits and risk when assessing devices
  • Removing the need to recertify devices under the MDR and IVDR
  • Allowing pre-submission dialogues with notified bodies
  • Establishing accelerated and precertification pathways
  • Building more centralized governance for addressing systematic regulatory issues
Continue reading Pathways’ Picks here.
×



Articles from David Filmore:

Regulatory & Reimbursement

Navigating De Novos: Engage, Respond, and Consider Postmarket Controls

Less than half of devices that pursued FDA’s De Novo classification as a route to market in recent years have had success as firms struggle to prove effectiveness for their novel low-to-moderate risk technologies. Advice from a CDRH official and expert consultant on the best ways for companies to build rapport and gain buy-in from reviewers and to take advantage of opportunities to win the benefit-risk balance with the help of postmarket planning.

Read Article